US Stock MarketDetailed Quotes

TOVX Theriva Biologics

Watchlist
  • 0.4195
  • +0.0096+2.33%
Close Apr 26 16:00 ET
  • 0.4077
  • -0.0118-2.81%
Post 18:56 ET
7.19MMarket Cap-367P/E (TTM)

Theriva Biologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-0.70%21.43M
-15.03%6.22M
-15.40%4.22M
15.80%5.82M
21.78%5.18M
51.19%21.58M
38.97%7.32M
52.24%4.99M
57.21%5.03M
67.60%4.25M
Selling and administrative expenses
-27.77%7.12M
-52.40%2.02M
-91.23%212K
74.37%2.69M
32.99%2.2M
52.27%9.86M
70.80%4.25M
85.42%2.42M
21.82%1.54M
16.63%1.66M
-General and administrative expense
-27.77%7.12M
-52.40%2.02M
-91.23%212K
74.37%2.69M
32.99%2.2M
52.27%9.86M
70.80%4.25M
85.42%2.42M
21.82%1.54M
16.63%1.66M
Research and development costs
22.08%14.31M
36.63%4.2M
55.88%4.01M
-10.10%3.13M
14.63%2.98M
50.29%11.72M
10.51%3.07M
30.32%2.57M
80.38%3.49M
132.29%2.6M
Operating profit
0.70%-21.43M
15.03%-6.22M
15.40%-4.22M
-15.80%-5.82M
-21.78%-5.18M
-51.19%-21.58M
-38.97%-7.32M
-52.24%-4.99M
-57.21%-5.03M
-67.60%-4.25M
Net non-operating interest income expense
181.05%1.44M
-0.95%312K
124.71%382K
1,365.38%381K
18,100.00%364K
8,433.33%512K
15,650.00%315K
8,400.00%170K
1,200.00%26K
2K
Non-operating interest income
181.05%1.44M
-0.95%312K
124.71%382K
1,365.38%381K
18,100.00%364K
8,433.33%512K
15,650.00%315K
8,400.00%170K
1,200.00%26K
--2K
Other net income (expense)
107.32%3K
-300.00%-4K
166.67%6K
55.56%-4K
126.09%6K
-41K
-1K
-9K
-9K
-23K
Gain on sale of security
107.32%3K
-300.00%-4K
166.67%6K
55.56%-4K
126.09%6K
---41K
---1K
---9K
---9K
---23K
Income before tax
5.31%-19.99M
15.62%-5.91M
20.62%-3.83M
-8.66%-5.44M
-12.52%-4.81M
-47.95%-21.11M
-33.06%-7M
-47.42%-4.83M
-56.78%-5.01M
-68.43%-4.27M
Income tax
-15.09%-1.64M
24.01%-424K
-57.31%-527K
32.52%-359K
-330K
-1.43M
-558K
-335K
-532K
0
Net income
6.79%-18.35M
14.90%-5.49M
26.44%-3.3M
-13.56%-5.08M
-4.80%-4.48M
-37.97%-19.69M
-22.46%-6.45M
-37.18%-4.49M
-40.13%-4.48M
-68.43%-4.27M
Net income continuous Operations
6.79%-18.35M
14.90%-5.49M
26.44%-3.3M
-13.56%-5.08M
-4.80%-4.48M
-37.97%-19.69M
-22.46%-6.45M
-37.18%-4.49M
-40.13%-4.48M
-68.43%-4.27M
Minority interest income
Net income attributable to the parent company
6.79%-18.35M
14.90%-5.49M
26.44%-3.3M
-13.56%-5.08M
-4.80%-4.48M
-37.98%-19.69M
-22.46%-6.45M
-37.18%-4.49M
-40.13%-4.48M
-68.49%-4.27M
Preferred stock dividends
Other preferred stock dividends
0
0
0
-95.41%340K
0
340K
Net income attributable to common stockholders
8.37%-18.35M
14.90%-5.49M
31.61%-3.3M
-13.56%-5.08M
-4.80%-4.48M
13.64%-20.03M
-22.46%-6.45M
-47.57%-4.83M
-40.13%-4.48M
62.71%-4.27M
Basic earnings per share
12.98%-1.14
25.00%-0.33
36.67%-0.19
-21.43%-0.34
3.23%-0.3
31.05%-1.31
-12.82%-0.44
-20.00%-0.3
-16.67%-0.28
76.15%-0.31
Diluted earnings per share
12.98%-1.14
25.00%-0.33
36.67%-0.19
-21.43%-0.34
3.23%-0.3
31.05%-1.31
-12.82%-0.44
-20.00%-0.3
-16.67%-0.28
76.15%-0.31
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -0.70%21.43M-15.03%6.22M-15.40%4.22M15.80%5.82M21.78%5.18M51.19%21.58M38.97%7.32M52.24%4.99M57.21%5.03M67.60%4.25M
Selling and administrative expenses -27.77%7.12M-52.40%2.02M-91.23%212K74.37%2.69M32.99%2.2M52.27%9.86M70.80%4.25M85.42%2.42M21.82%1.54M16.63%1.66M
-General and administrative expense -27.77%7.12M-52.40%2.02M-91.23%212K74.37%2.69M32.99%2.2M52.27%9.86M70.80%4.25M85.42%2.42M21.82%1.54M16.63%1.66M
Research and development costs 22.08%14.31M36.63%4.2M55.88%4.01M-10.10%3.13M14.63%2.98M50.29%11.72M10.51%3.07M30.32%2.57M80.38%3.49M132.29%2.6M
Operating profit 0.70%-21.43M15.03%-6.22M15.40%-4.22M-15.80%-5.82M-21.78%-5.18M-51.19%-21.58M-38.97%-7.32M-52.24%-4.99M-57.21%-5.03M-67.60%-4.25M
Net non-operating interest income expense 181.05%1.44M-0.95%312K124.71%382K1,365.38%381K18,100.00%364K8,433.33%512K15,650.00%315K8,400.00%170K1,200.00%26K2K
Non-operating interest income 181.05%1.44M-0.95%312K124.71%382K1,365.38%381K18,100.00%364K8,433.33%512K15,650.00%315K8,400.00%170K1,200.00%26K--2K
Other net income (expense) 107.32%3K-300.00%-4K166.67%6K55.56%-4K126.09%6K-41K-1K-9K-9K-23K
Gain on sale of security 107.32%3K-300.00%-4K166.67%6K55.56%-4K126.09%6K---41K---1K---9K---9K---23K
Income before tax 5.31%-19.99M15.62%-5.91M20.62%-3.83M-8.66%-5.44M-12.52%-4.81M-47.95%-21.11M-33.06%-7M-47.42%-4.83M-56.78%-5.01M-68.43%-4.27M
Income tax -15.09%-1.64M24.01%-424K-57.31%-527K32.52%-359K-330K-1.43M-558K-335K-532K0
Net income 6.79%-18.35M14.90%-5.49M26.44%-3.3M-13.56%-5.08M-4.80%-4.48M-37.97%-19.69M-22.46%-6.45M-37.18%-4.49M-40.13%-4.48M-68.43%-4.27M
Net income continuous Operations 6.79%-18.35M14.90%-5.49M26.44%-3.3M-13.56%-5.08M-4.80%-4.48M-37.97%-19.69M-22.46%-6.45M-37.18%-4.49M-40.13%-4.48M-68.43%-4.27M
Minority interest income
Net income attributable to the parent company 6.79%-18.35M14.90%-5.49M26.44%-3.3M-13.56%-5.08M-4.80%-4.48M-37.98%-19.69M-22.46%-6.45M-37.18%-4.49M-40.13%-4.48M-68.49%-4.27M
Preferred stock dividends
Other preferred stock dividends 000-95.41%340K0340K
Net income attributable to common stockholders 8.37%-18.35M14.90%-5.49M31.61%-3.3M-13.56%-5.08M-4.80%-4.48M13.64%-20.03M-22.46%-6.45M-47.57%-4.83M-40.13%-4.48M62.71%-4.27M
Basic earnings per share 12.98%-1.1425.00%-0.3336.67%-0.19-21.43%-0.343.23%-0.331.05%-1.31-12.82%-0.44-20.00%-0.3-16.67%-0.2876.15%-0.31
Diluted earnings per share 12.98%-1.1425.00%-0.3336.67%-0.19-21.43%-0.343.23%-0.331.05%-1.31-12.82%-0.44-20.00%-0.3-16.67%-0.2876.15%-0.31
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg